During the past decade, Drexel University College of Medicine - Center City Hahnemann Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drexel University College of Medicine - Center City Hahnemann Campus" #1 sponsor was "Eastern Cooperative Oncology Group" with 1 trials, followed by "Fox Chase Cancer Center" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drexel University College of Medicine - Center City Hahnemann Campus" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Medical Research Council" with 1 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Drexel University College of Medicine - Center City Hahnemann Campus" are "Leukemia" (2 trials), "Breast Cancer" (1 trials), "Lung Cancer" (1 trials), "Lymphoma" (1 trials) and "Sarcoma" (1 trials). Many other conditions were trialed in "Drexel University College of Medicine - Center City Hahnemann Campus" in a lesser frequency.

Most popular intervention types in "Drexel University College of Medicine - Center City Hahnemann Campus" are "Drug" (4 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "3-dimensional conformal accelerated partial breast irradiation" (1 trials), "Cyclophosphamide" (1 trials), "Cytarabine" (1 trials) and "Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Drexel University College of Medicine - Center City Hahnemann Campus" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Drexel University College of Medicine - Center City Hahnemann Campus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Drexel University College of Medicine - Center City Hahnemann Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Drexel University College of Medicine - Center City Hahnemann Campus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".